Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
21SEP

Clifford quits ARIA chair for Anthropic

2 min read
16:52UTC

Matt Clifford stepped down as chair of the Advanced Research and Invention Agency on 7 September, five days after announcing a move to Anthropic and on the day a Commons committee published its concern.

TechnologyDeveloping
Key takeaway

ARIA lost its chair to a private appointment and has a funding call open without a permanent replacement.

Matt Clifford resigned as chair of the Advanced Research and Invention Agency (ARIA), Britain's high-risk research funder, on 7 September, five days after announcing that he was joining Anthropic as managing director for international affairs⁠1. He had initially intended to keep the ARIA chair alongside the new role.

Dame Chi Onwurah, who chairs the Commons Science, Innovation and Technology Committee, wrote to government the following week flagging the conflict between chairing a public funder of frontier research and working for a company operating in the field it funds. Clifford stepped down on the day her committee published its comment. Onwurah says she expects a detailed response from government on how the conflict arose and what safeguards protect ARIA's governance.

Chemistry World reports that government asked Clifford to stay on in a transitional capacity until 6 November while a selection process runs⁠2. ARIA opened the first funding call of its olfactory perception programme on 12 August, one of four programmes that UK Research and Innovation, Innovate UK and ARIA opened between them that month. The agency commits public money into work sitting one step from commercial exploitation, so the identity of the person signing off those commitments carries weight beyond the courtesy of a register entry.

The resolution arrived quickly and by the ordinary route: a select committee named the structural problem, and the appointee left the public post rather than the private one. No finding of wrongdoing attaches to Clifford. What remains open is the process question Onwurah has put to government, which is how a conflict of this shape reached the point of needing a resignation at all.

Deep Analysis

In plain English

Matt Clifford ran the Advanced Research and Invention Agency (ARIA), a British body that funds ambitious scientific research. He quit days after announcing a new job at Anthropic, a US artificial intelligence company, once a House of Commons committee pointed out the conflict between the two roles. ARIA was deliberately designed with fewer of the usual civil service rules, to let it move fast and attract people from outside government. That same design means fewer built-in checks catch a conflict like this before it becomes public.

Deep Analysis
Root Causes

The Advanced Research and Invention Agency Act 2022 gave ARIA deliberately light governance, modelled on DARPA's high-risk, high-reward funding freedom, and exempted its leadership from several standard Civil Service constraints in order to attract figures from outside government.

That same exemption is why a conflict here surfaces through select committee scrutiny rather than a standing pre-appointment ethics check: ARIA's chair role was not built with a DARPA-grade conflicts regime attached to it.

What could happen next?
  • Consequence

    ARIA will need to appoint a new chair while its light-touch governance model faces renewed scrutiny from the same select committee that flagged this conflict.

  • Risk

    Other ARIA leadership figures who hold parallel private-sector roles face the same exposure, since the structural gap Clifford's resignation revealed has not been closed.

First Reported In

Update #15 · Nscale takes $103.4bn of contracts to NYSE

Science, Innovation and Technology Committee· 21 Sept 2026
Read original →
Causes and effects
This Event
Clifford quits ARIA chair for Anthropic
Britain's high-risk research funder is running a live funding call without a permanent chair.
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.